BIO ADVANCE

A Seven-Point Plan to Secure America’s Biotech Leadership
 

America pioneered the modern biotechnology industry and has led the world in developing lifesaving medicines for decades. Today, the U.S. biotech industry generates $3.2 trillion in economic output and directly employs more than 2.3 million Americans.

But America's biotech leadership is at risk.

China is rapidly expanding its biotech industry, threatening American jobs, national security, and medical innovation. It now accounts for more than a quarter of the world's clinical trials.

The global biotech race is our generation's Space Race. America needs a plan to win.

That's why BIO developed BioAdvance: Securing America's Biotech Century - a seven-point action plan to secure America's position as the world's biotechnology powerhouse.

Three Areas for Action

1. Coordinate:

   • Establish a permanent White House Office of Biotechnology to coordinate federal policy, set clear goals, and keep America ahead of global competitors.

2. Accelerate:

   • Speed up the path to first-in-human clinical studies.

   • Modernize and streamline drug development.

   • Improve patient access to clinical trials.

3. Build:

   • Sustain support for biomedical research.

   • Expand U.S. biomanufacturing capacity and expertise.

   • Strengthen intellectual property protections and access to capital.
      

Explore & Download BioAdvance

Momentum is building in Washington to meet that challenge. BioAdvance seeks to channel that momentum into a coordinated national strategy.
 

Watch: BIO President and CEO John F. Crowley explains what's at stake in the global biotech race - and how BioAdvance offers a path forward.